COSCIENS Biopharma Inc. Profit Loss Before Tax
COSCIENS Biopharma Inc. (CSCIF) reported Profit Loss Before Tax of -$10.35 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Notes
ifrs-full:ProfitLossBeforeTax · last filed 2026-03-25
- COSCIENS Biopharma Inc. profit loss before tax for the quarter ending 2025-12-31 was -$2.17M.
- COSCIENS Biopharma Inc. profit loss before tax for the quarter ending 2025-09-30 was -$1.82M.
- COSCIENS Biopharma Inc. profit loss before tax for the quarter ending 2025-06-30 was -$2.70M.
- COSCIENS Biopharma Inc. profit loss before tax for the quarter ending 2025-03-31 was -$3.65M.
| Period end | Profit Loss Before Tax 3 month | Profit Loss Before Tax 3 month as first filed | Profit Loss Before Tax 6 month | Profit Loss Before Tax 6 month as first filed | Profit Loss Before Tax 9 month | Profit Loss Before Tax 9 month as first filed | Profit Loss Before Tax 12 month | Profit Loss Before Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | -$2.17M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-25 | -$3.99M derived: sum of 2 quarters · filed 2026-03-25 | -$6.69M derived: sum of 3 quarters · filed 2026-03-25 | -$10.35M 20-F · filed 2026-03-25 | ||||
| 2025-09-30 | -$1.82M 6-K · filed 2025-11-12 | -$4.52M derived: sum of 2 quarters · filed 2025-11-12 | -$8.18M 6-K · filed 2025-11-12 | -$13.82M derived: sum of 4 quarters · filed 2026-03-25 | ||||
| 2025-06-30 | -$2.70M 6-K · filed 2025-08-14 | -$6.36M 6-K · filed 2025-08-14 | -$12.00M derived: sum of 3 quarters · filed 2026-03-25 | -$17.87M derived: sum of 4 quarters · filed 2026-03-25 | ||||
| 2025-03-31 | -$3.65M 6-K · filed 2025-05-13 | -$9.30M derived: sum of 2 quarters · filed 2026-03-25 | -$15.17M derived: sum of 3 quarters · filed 2026-03-25 | -$17.07M derived: sum of 4 quarters · filed 2026-03-25 | ||||
| 2024-12-31 | -$5.65M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-25 | -$11.52M derived: sum of 2 quarters · filed 2026-03-25 | -$13.41M derived: sum of 3 quarters · filed 2026-03-25 | -$15.22M 20-F · filed 2026-03-25 | ||||
| 2024-09-30 | -$5.87M 6-K · filed 2025-11-12 | -$7.76M derived: sum of 2 quarters · filed 2025-11-12 | -$9.58M 6-K · filed 2025-11-12 | -$11.50M derived: sum of 4 quarters · filed 2026-03-25 | ||||
| 2024-06-30 | -$1.90M 6-K · filed 2025-08-14 | -$3.71M 6-K · filed 2025-08-14 | -$5.63M derived: sum of 3 quarters · filed 2026-03-25 | -$6.62M derived: sum of 4 quarters · filed 2026-03-25 | ||||
| 2024-03-31 | -$1.81M 6-K · filed 2025-05-13 | -$5.75M 6-K · filed 2024-05-16 | -$3.74M derived: sum of 2 quarters · filed 2026-03-25 | -$4.72M derived: sum of 3 quarters · filed 2026-03-25 | -$5.82M derived: sum of 4 quarters · filed 2026-03-25 | |||
| 2023-12-31 | -$1.92M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-25 | -$2.91M derived: sum of 2 quarters · filed 2026-03-25 | -$4.01M derived: sum of 3 quarters · filed 2026-03-25 | -$4.37M 20-F · filed 2026-03-25 | -$16.55M 20-F · filed 2024-03-27 | |||
| 2023-09-30 | -$988.00K 6-K · filed 2024-11-12 | -$4.14M 6-K · filed 2023-11-09 | -$2.08M derived: sum of 2 quarters · filed 2024-11-12 | -$2.45M 6-K · filed 2024-11-12 | -$10.92M 6-K · filed 2023-11-09 | $8.47M derived: sum of 4 quarters · filed 2025-04-09 | ||
| 2023-06-30 | -$1.09M 6-K · filed 2024-08-13 | -$2.52M 6-K · filed 2023-08-09 | -$1.46M 6-K · filed 2024-08-13 | -$6.77M 6-K · filed 2023-08-09 | $9.45M derived: sum of 3 quarters · filed 2025-04-09 | $6.03M derived: sum of 4 quarters · filed 2025-04-09 | ||
| 2023-03-31 | -$4.25M 6-K · filed 2024-05-16 | $10.55M derived: sum of 2 quarters · filed 2025-04-09 | $7.13M derived: sum of 3 quarters · filed 2025-04-09 | $2.91M derived: sum of 4 quarters · filed 2025-04-09 | ||||
| 2022-12-31 | $14.80M derived: 20-F 12 month − 6-K 9 month · filed 2025-04-09 | $11.38M derived: sum of 2 quarters · filed 2025-04-09 | $7.17M derived: sum of 3 quarters · filed 2025-04-09 | $4.53M 20-F · filed 2025-04-09 | -$22.73M 20-F · filed 2023-03-23 | |||
| 2022-09-30 | -$3.42M 6-K · filed 2023-11-09 | -$7.64M derived: sum of 2 quarters · filed 2023-11-09 | -$10.28M 6-K · filed 2023-11-09 | -$13.15M derived: sum of 4 quarters · filed 2024-07-17 | ||||
| 2022-06-30 | -$4.22M 6-K · filed 2023-08-09 | -$6.86M 6-K · filed 2023-08-09 | -$9.73M derived: sum of 3 quarters · filed 2024-07-17 | -$11.66M derived: sum of 4 quarters · filed 2024-07-17 | ||||
| 2022-03-31 | -$2.64M 6-K · filed 2023-05-09 | -$5.51M derived: sum of 2 quarters · filed 2024-07-17 | -$7.45M derived: sum of 3 quarters · filed 2024-07-17 | -$9.53M derived: sum of 4 quarters · filed 2024-07-17 | ||||
| 2021-12-31 | -$2.87M derived: 20-F/A 12 month − 6-K 9 month · filed 2024-07-17 | -$4.81M derived: sum of 2 quarters · filed 2024-07-17 | -$6.89M derived: sum of 3 quarters · filed 2024-07-17 | -$8.48M 20-F/A · filed 2024-07-17 | ||||
| 2021-09-30 | -$1.93M 6-K · filed 2022-11-03 | -$1.70M 6-K · filed 2021-11-04 | -$4.02M derived: sum of 2 quarters · filed 2022-11-03 | -$5.60M 6-K · filed 2022-11-03 | -$5.31M 6-K · filed 2021-11-04 | -$6.52M derived: sum of 4 quarters · filed 2024-02-15 | ||
| 2021-06-30 | -$2.08M 6-K/A · filed 2022-08-04 | -$2.04M 6-K · filed 2021-08-05 | -$3.67M 6-K/A · filed 2022-08-04 | -$3.61M 6-K · filed 2021-08-05 | -$4.59M derived: sum of 3 quarters · filed 2024-02-15 | -$5.72M derived: sum of 4 quarters · filed 2024-02-15 | ||
| 2021-03-31 | -$1.59M 6-K · filed 2022-05-11 | -$1.57M 6-K · filed 2021-05-05 | -$2.50M derived: sum of 2 quarters · filed 2024-02-15 | -$3.64M derived: sum of 3 quarters · filed 2024-02-15 | -$7.09M derived: sum of 4 quarters · filed 2024-02-15 | |||
| 2020-12-31 | -$916.00K derived: 20-F/A 12 month − 6-K 9 month · filed 2024-02-15 | -$2.05M derived: sum of 2 quarters · filed 2024-02-15 | -$5.50M derived: sum of 3 quarters · filed 2024-02-15 | -$4.72M 20-F/A · filed 2024-02-15 | ||||
| 2020-09-30 | -$1.14M 6-K · filed 2021-11-04 | -$4.59M derived: sum of 2 quarters · filed 2021-11-04 | -$3.81M 6-K · filed 2021-11-04 | -$5.00M derived: sum of 4 quarters · filed 2022-03-29 | ||||
| 2020-06-30 | -$3.45M 6-K · filed 2021-08-05 | -$2.67M 6-K · filed 2021-08-05 | -$3.87M derived: sum of 3 quarters · filed 2022-03-29 | -$4.20M derived: sum of 4 quarters · filed 2022-03-29 | ||||
| 2020-03-31 | $779.00K 6-K · filed 2021-05-05 | -$415.00K derived: sum of 2 quarters · filed 2022-03-29 | -$746.00K derived: sum of 3 quarters · filed 2022-03-29 | -$540.00K derived: sum of 4 quarters · filed 2022-03-29 | ||||
| 2019-12-31 | -$1.19M derived: 20-F 12 month − 6-K 9 month · filed 2022-03-29 | -$1.52M derived: sum of 2 quarters · filed 2022-03-29 | -$1.32M derived: sum of 3 quarters · filed 2022-03-29 | -$6.23M 20-F · filed 2022-03-29 | ||||
| 2019-09-30 | -$331.00K 6-K · filed 2019-11-07 | -$125.00K derived: sum of 2 quarters · filed 2019-11-07 | -$5.04M 6-K · filed 2019-11-07 | |||||
| 2019-06-30 | $206.00K 6-K · filed 2019-08-13 | -$4.71M 6-K · filed 2019-08-13 | ||||||
| 2018-12-31 | -$5.76M derived: 20-F 12 month − 6-K 9 month · filed 2020-03-31 | -$8.82M derived: sum of 2 quarters · filed 2020-03-31 | -$11.65M derived: sum of 3 quarters · filed 2020-03-31 | $9.64M 20-F · filed 2020-03-31 | ||||
| 2018-09-30 | -$3.06M 6-K · filed 2019-11-07 | -$5.89M derived: sum of 2 quarters · filed 2019-11-07 | $15.40M 6-K · filed 2019-11-07 | |||||
| 2018-06-30 | -$2.83M 6-K · filed 2019-08-13 | $18.46M 6-K · filed 2019-08-13 | ||||||
| 2017-12-31 | -$20.27M 20-F · filed 2020-03-31 | |||||||
| 2016-12-31 | -$24.96M 20-F · filed 2019-04-01 | |||||||
| 2015-12-31 | -$50.23M 20-F · filed 2018-03-28 |